GlassScriptPhysician profile
Bruce Darrell Larsen
NPI 1922189372
$1,586.40
in general payments reported to CMS, 2019-2025
25 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.59 · 2020: $15.32 · 2022: $341 · 2023: $319 · 2024: $354 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.07 | 2022-2025 | |
| Amgen INC. | $154.67 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $111.94 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $87.90 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $81.03 | 2019-2024 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Axsome Therapeutics, INC. | $73.20 | 2022-2023 | Sunosi |
| Glaxosmithkline, LLC. | $69.24 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $55.29 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Phathom Pharmaceuticals, INC. | $52.68 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $52.47 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $44.11 | 2022 | |
| Idorsia Pharmaceuticals US INC | $43.83 | 2022-2023 | Quviviq |
| Sanofi Pasteur INC. | $39.79 | 2019-2022 | |
| Exact Sciences Corporation | $34.68 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $33.38 | 2023-2024 | Veozah |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $32.40 | 2023-2024 | Nexplanon, Nuvaring |
| Seqirus USA INC | $29.64 | 2022-2024 | Fluad, Flucelvax |
| Intuitive Surgical, INC. | $24.52 | 2024 | |
| Kyowa Kirin, INC. | $21.64 | 2024 | Crysvita |
| Cranial Technologies, INC | $19.66 | 2023 | Doc Band |
| Tris Pharma INC | $18.04 | 2023 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $17.06 | 2024 | Spravato |
| Inspire Medical Systems, INC. | $16.82 | 2025 | Inspire |
| Lucid Diagnostics INC. | $16.15 | 2023 | |
| Lundbeck LLC | $14.19 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.